Peptide Comparison
Pentapeptide-18 vs Rigin
Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.
Data-derived verdict
Pentapeptide-18 and Rigin share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). On the catalogued data layer Pentapeptide-18 has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Pentapeptide-18's evidence base is currently denser.
Evidence at a glance
FDA-approved Phase 3 Phase 2 / approved abroad Anecdotal + animal Preclinical / flagged
Shared safety considerations
Both compounds share these reported concerns: minimal. Open each peptide page for the full risk paragraph and source citations.
Side-by-side
| Pentapeptide-18 | Rigin | |
|---|---|---|
| Class | Cosmetic peptide; enkephalin mimetic | Cosmetic lipopeptide (anti-inflammatory) |
| Drug class | Dermatologic | Dermatologic |
| Mechanism | Enkephalin mimetic; modulates SNAP-25 at muscle-neuron interface (topical) | Suppresses IL-6 secretion by fibroblasts; reduces inflammaging |
| Route | Topical | Topical |
| Half-life | Topical | Topical |
| Dosage (research) | Topical 2-10% | Topical 2-4% |
| Evidence tier | Cosmetic Clinical Studies | Cosmetic Clinical Studies |
| Research depth | 11 indexed | 31 indexed |
| Availability | Cosmetic | Cosmetic |
| Reported risks | Minimal | Minimal |
Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.
Frequently asked questions
Should I pick Pentapeptide-18 or Rigin?
Pentapeptide-18 and Rigin share the cosmetic class and carry roughly equivalent evidence (Cosmetic Clinical Studies / Cosmetic Clinical Studies). On the catalogued data layer Pentapeptide-18 has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; Pentapeptide-18's evidence base is currently denser.
What is the difference between Pentapeptide-18 and Rigin?
Pentapeptide-18 is classed as Cosmetic peptide; enkephalin mimetic; Rigin is classed as Cosmetic lipopeptide (anti-inflammatory). Reported mechanism: Pentapeptide-18, Enkephalin mimetic; modulates SNAP-25 at muscle-neuron interface (topical); Rigin, Suppresses IL-6 secretion by fibroblasts; reduces inflammaging. Reported half-life: Pentapeptide-18, Topical; Rigin, Topical. Routes in published studies: Pentapeptide-18, Topical; Rigin, Topical.
Which has stronger evidence, Pentapeptide-18 or Rigin?
Pentapeptide-18 and Rigin sit on the same rung of PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. Pentapeptide-18 is graded Cosmetic Clinical Studies, with 3 cited sources on its reference page and 11 indexed studies. Rigin is graded Cosmetic Clinical Studies, with 2 cited sources on its reference page and 31 indexed studies.
Which is more accessible, Pentapeptide-18 or Rigin?
Neither Pentapeptide-18 nor Rigin is an FDA-approved drug. Catalog status: Pentapeptide-18, Cosmetic; Rigin, Cosmetic.
Are Pentapeptide-18 and Rigin ever combined?
Pentapeptide-18 and Rigin appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.
Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.
Loading interactive view…